Evidence map›Paper›PMID 37726707›Full record

SynthesisBMC cancer2023

Sleep disturbances and the risk of lung cancer: a meta-epidemiological study.

Tong Zhou, Zichen Wang, Chenxi Qiao, Shuo Wang, Shuaihang Hu, Xinyan Wang, Xiumei Ma, Dandan Wang, Jinglei Li, Zheng Li and 1 more

Open access · goldAbstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Sleep and Cancer.Cancers · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Tong Zhou *Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beixian'ge Street No. 5 Xicheng District, Beijing, China.
Zichen Wang *Department of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beixian'ge Street No. 5 Xicheng District, Beijing, China.
Chenxi QiaoDepartment of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beixian'ge Street No. 5 Xicheng District, Beijing, China.
Shuo WangDepartment of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beixian'ge Street No. 5 Xicheng District, Beijing, China.
Shuaihang HuDepartment of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beixian'ge Street No. 5 Xicheng District, Beijing, China.
Xinyan WangDepartment of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beixian'ge Street No. 5 Xicheng District, Beijing, China.
Xiumei MaDepartment of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beixian'ge Street No. 5 Xicheng District, Beijing, China.
Dandan WangDepartment of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beixian'ge Street No. 5 Xicheng District, Beijing, China.
Jinglei LiDepartment of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beixian'ge Street No. 5 Xicheng District, Beijing, China.
Zheng LiDepartment of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beixian'ge Street No. 5 Xicheng District, Beijing, China.
Wei HouDepartment of Oncology, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beixian'ge Street No. 5 Xicheng District, Beijing, China. houweitcm@163.com.
Guang’anmen Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine No. ZYYCXTD-C-202205National Natural Science Foundation of China No. 82074239Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences No. CI2021A01801
6 · The paper itself

Abstract

backgroundThe relationship between sleep disturbances and lung cancer is complex and bidirectional. This meta-epidemiological study aimed to explore the potential association between sleep disruption and the risk of pulmonary cancer.

methodsWe conducted a comprehensive literature search of the PubMed, Embase, Cochrane Library, and Web of Science databases to retrieve relevant studies. We employed the Newcastle-Ottawa Scale to assess the quality of the observational studies. Stata 17.0 was used to synthesize and conduct a meta-analysis of odds ratios (ORs) and corresponding 95% confidence intervals (CIs). We used funnel plot analysis and Egger's regression test to evaluate potential publication bias.

resultsA total of 11 studies were included with 469,691 participants. The methodological quality of the included studies ranged from moderate to high. Compared with 7-8 h of sleep time, short sleep duration was associated with a 13% higher lung cancer risk [OR, 1.13; 95%CI: 1.02-1.25; I DISCUSSION: This systematic review is the first one which observes positive correction between sleep disturbances and the incidence of lung cancer. While the plausible mechanism is not clear, it is hypothesized that the association of short sleep duration and lung cancer mainly mediated by melatonin secretion and the immune-inflammatory balance. Further studies are needed to examine whether other risk factors, such as age, occupation, cumulative effect of sleep disturbances might mediate the relationship between sleep disturbances and lung cancer risk.

conclusionThe present study revealed that insufficient and excessive sleep duration, insomnia symptoms, and evening chronotype were significantly predictive of an increased risk of lung cancer. This finding underscores the need to account for sleep disturbances as an independent risk factor for evaluating susceptibility to lung cancer.

trial registrationCRD42023405351.

Indexed as

Lung NeoplasmsSleep Initiation and Maintenance DisordersSleep Wake DisordersEpidemiologic StudiesHumansSleepEpidemiological studyLung neoplasmMetaSleep disturbances

Identifiers

PMID37726707
PMCPMC10510222
OpenAlexW4386864680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.